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Viral encephalitis is a global health concern. The ability of a virus to modulate the immune response can have a pivotal effect on the
course of disease and the fate of the infected host. In this study, we sought to understand the immunological basis for the fatal encephalitis
following infection with the murine coronavirus, mouse hepatitis virus (MHV)-JHM, in contrast with the more attenuated MHV-A59.
Distinct glial cell cytokine and chemokine response patterns were observed within 3 days after infection, became progressively more
polarized during the course of infection and with the infiltration of leukocytes. In the brain, MHV-JHM infection induced strong
accumulation of IFNh mRNA relative to IFNg mRNA. This trend was reversed in MHV-A59 infection and was accompanied by increased
CD8 T cell infiltration into brain compared to MHV-JHM infection. Increased apoptosis appeared to contribute to the diminished presence of
CD8 T cells in MHV-JHM-infected brain with the consequence of a lower potential for IFNg production and antiviral activity. MHV-JHM
infection also induced sustained mRNA accumulation of the innate immune response products interleukin (IL)-6 and IL-1. Furthermore, high
levels of macrophage-inflammatory protein (MIP)-1a, MIP-1h, and MIP-2 mRNA were observed at the onset of MHV-JHM infection and
correlated with a marked elevation in the number of macrophages in the brain on day 7 compared to MHV-A59 infection. These observations
indicate that differences in the severity of viral encephalitis may reflect the differential ability of viruses to stimulate innate immune responses
within the CNS and subsequently the character of infiltrating leukocyte populations.
D 2003 Elsevier Inc. All rights reserved.Keywords: Neuroimmunology; Viral; Cytokines; Chemokines; T LymphocytesIntroduction
The impact of emerging and reemerging viral induced
encephalitis is being felt globally (Shoji et al., 2002). The
outcome of viral encephalitis can be considered the result of
a competition between the virus and the host immune
system. The parameters governing this outcome include
the intrinsic virulence of the infecting virus, its tropism,
replicative potential, and interactions with the immune
system. In addition, the virus infection triggers a host
immune response which may be protective or may contrib-
ute to the disease process (reviewed in (Noseworthy, 1999;0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.09.023
Abbreviations: MHV, mouse hepatitis virus; MIF, macrophage migra-
tion inhibitory factor; MIP, macrophage-inflammatory protein.
* Corresponding author. Division of Virology, Department of Neuro-
pharmacology, The Scripps Research Institute, Maildrop CVN-8, 10550
North Torrey Pines Road, La Jolla, CA 92037. Fax: +1-858-784-7162.
E-mail address: buchm@scripps.edu (M.J. Buchmeier).Pavesi et al., 1992)). Thus, the balance of these factors
within the CNS may result in a return to homeostasis, the
development of autoimmunity, or the occurrence of fatal
encephalitis.
A variety of murine coronavirus strains differ radically in
their pathogenic potential and disease outcome rendering
them useful models to study the generation of immune
responses critical to this balance. Infection with the mouse
hepatitis virus (MHV)-JHM causes severe encephalitis with
a high mortality when inoculated intracranially or intrana-
sally into susceptible adult mice (Phillips et al., 1999). In
contrast, infection with the mildly neurovirulent MHV-A59
strain results in viral clearance and the development of
demyelinating lesions resembling those in multiple sclerosis
(Lai and Stohlman, 1981; Lavi et al., 1984; Woyciechowska
et al., 1984; Zou et al., 1999). Although these viruses share
many features, differences in the spike glycoprotein, hem-
agglutinin/esterase, and other proteins may be responsible
for the enhanced capacity of MHV-JHM to infect the brain.
Fig. 1. Viral titers and disease scores. Mice were infected with MHV-JHM
and MHV-A59 at doses indicated. Brain viral titers were determined by
plaque assay. *By day 9, mice infected with MHV-JHM generally had
succumbed to infection, whereas replicating virus was not detected in
MHV-A59-infected brains. Mean PFU/ml F SE are shown (n = 4–8 mice
per group). Disease scores were assessed on day 7, the peak of acute
encephalitis (n = 15 mice/group). On day 7, cells were isolated from
infected brains as described in Materials and Methods. Live cells were
identified by trypan blue dye exclusion.
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gest that MHV-JHM and MHV-A59 are able to infect
astrocytes, oligodendrocytes, and to a lesser degree neurons,
MHV-JHM invades the brain more extensively (Lavi et al.,
1999; Phillips et al., 2002; van Berlo et al., 1989; Woycie-
chowska et al., 1984). Variation is also apparent in the CD8
T cell epitopes, such that of the two known epitopes on the
MHV-JHM spike protein (S510 and S598), only one (S598)
is shared by MHV-A59 due to a deletion in the MHV-A59
spike protein (Bergmann et al., 1996; Castro and Perlman,
1996). In addition, it has been speculated that MHV-A59
may contain unidentified CD8 epitopes (Marten et al.,
2001).
It is now appreciated that glial and neuronal cells are
capable of responding to infection by releasing chemokines
and cytokines that trigger innate immune responses in the
absence of peripheral immune cells (Olson et al., 2001).
Release of type I (IFNa/h) and type II (IFNg) interferons
and production of pro-inflammatory cytokines such as
interleukin (IL)-6 and IL-1 are important early events in
response to viral infection (Parra et al., 1997; LeBlanc et al.,
1999). IFNg, in particular, is critical in resolving MHV
infection (Marten et al., 2001; Parra et al., 1999; Schijns et
al., 1998). The production of innate immune mediators, such
as IL-12, IL-4, and interferons, acts to establish a microen-
vironment capable of directing adaptive T and B cell
responses; whereas, production of RANTES, macrophage-
inflammatory protein (MIP), and other chemokines acts to
recruit T cells and macrophages into the CNS following
infection (Lane et al., 1998; Liu and Lane, 2001). This
migration in response to chemokines is reenforced later by
the infiltrating leukocytes themselves. These cells can
provide protective immunity against CNS infections, as
demonstrated by the requirement of cytolytic CD8 T cell
activity in the clearance of MHV infections (Bergmann et
al., 1999; Gombold et al., 1995; Marten et al., 2001).
However, an inappropriate combination of these same
factors or timing of their release may result in the initiation
of neurologic disease (Olsson, 1995). Thus, the quality and
magnitude of the innate and adaptive responses can influ-
ence both the recovery from infection and the development
of immunopathology.
Much attention has been given to understanding how
immune responses participate in demyelinating disease. In
this study, we sought to understand how viral modulation of
early immune responses might influence the outcome of
CNS disease following infection with the highly neuro-
virulent virus, MHV-JHM. MHV-JHM was administered
intracranially in the absence of immune manipulation result-
ing in fatal encephalomyelitis. Chemokine, cytokine, and
cellular immune responses in the CNS compartment were
documented and compared against mildly neurovirulent
MHV-A59 infection. The lack of MHV-JHM clearance
was associated with diminished IFNg and CD8 T cell
responses. However, the expression of IL-6 and IFNh
mRNA was unabated. In contrast, mice infected withMHV-A59 exhibited decreasing accumulation of IL-6 and
IFNh mRNA, combined with early and consistent IFNg
transcripts that corresponded with the influx of CD8 T cells
into the CNS, and control of viral replication by 7 days after
infection. Furthermore, MHV-JHM infection was marked by
high levels of MIP-1a, MIP-1h, and MIP-2 mRNA corre-
lating with a greater infiltration of macrophages into the
brain compared to that observed in MHV-A59-infected
animals. The data presented in this report highlight the
crucial role that viral induction of early innate immune
responses may have in outcome of disease within the CNS.Results
Viral titers and disease severity
To better understand how immune responses elicited by a
virus might contribute to fatal encephalitis, C57Bl/6 mice
were injected intracranially with MHV-JHM or the control
virus MHV-A59. The viral burden within the brain was
assessed on days 3, 5, and 7 after inoculation. MHV-JHM
Fig. 2. MHV-JHM infection induces sustained accumulation of IFNh
mRNA. Mice were infected intracranially with MHV-JHM, control virus,
and saline. On days 3, 5, and 7 p.i, animals were perfused and brains
were harvested. Total RNA was extracted and analyzed by RPA. ‘‘S’’
indicates saline-injected mice. Two representative samples shown from
four experiments. Mean band densities were calculated using NIH Image
1.161 software reflective of signal intensity. Band densities for IFNg and
IFNh were normalized against corresponding L32 (housekeeping) band
densities and averaged. To compare the relative difference in IFNh and
IFNg mRNA accumulation, the average band densities were expressed as
ratios.
Fig. 3. Diminished CD8 T cell infiltration following MHV-JHM infection. Mice we
were isolated from infected brains and stained for either anti-CD8, anti-CD4,
experiment for each of anti-CD8, anti-CD4, or anti-NK1.1 staining is shown. (B)
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remained elevated (Fig. 1). In contrast, following MHV-A59
infection, initially high titers on day 5 were reduced by day
7 and undetectable by day 9.
Disease was scored on day 7, at the peak of encephalitis
for both viruses. At equivalent doses of 10 PFU, MHV-JHM
infection resulted in considerably more severe disease than
MHV-A59 (scores of 3.5 F 1.0 vs. 1.2 F 0.7, respectively;
Fig. 1). MHV-A59 needed to be given at 1000 PFU to
induce similar disease scores on day 7 as MHV-JHM at 10
PFU. Therefore, MHV-A59 was also used at 1000 PFU to
provide a control that more closely approximated the
severity of clinical disease seen in MHV-JHM infection.
Examining immune responses from viral infections resulting
in similar disease scores increased our confidence that the
responses measured following MHV-JHM infection were a
function of viral activity and not merely secondary to the
more severe clinical disease seen in MHV-JHM infection.
Mononuclear cells were isolated from infected brains and
the total number of infiltrating immune cells was estimated.
The numbers of inflammatory cells isolated from MHV-
JHM-infected brains were equivalent or slightly higher thanre inoculated with MHV-JHM and MHV-A59. On day 7, mononuclear cells
or anti-NK1.1, and analyzed by FACS analysis. (A) One representative
Means F SE for 4–6 mice/N experiments is shown.
J.D. Rempel et al. / Virology 318 (2004) 381–392384the number of cells from MHV-A59-infected brains, inde-
pendent of the MHV-A59 dose (Fig. 1). This indicated that
the high mortality among MHV-JHM infected mice was not
due to a failure to induce mononuclear cell infiltration into
the CNS.
MHV-JHM infection induces enhanced IFNb and reduced
IFNc transcript levels
The nature of the immune response induced by MHV-
JHM infection was evaluated by examining cytokine mRNAFig. 4. MHV-JHM infection results in reduced IFNg production within the CNS. C
CD3 in the presence of brefeldin A (mean percentsF SE shown reflect 4–6 mice p
(A) Stimulation with S510 peptide, following MHV-A59 infection, and an irrelevan
cells. Percentages depict the IFNg+ CD8 cells in the upper right-hand quadrant from
experiment due to the number of cells isolated from brains. (B) Mean percentages
hand quadrants of the graphs. (C) The percentage of IFNg+ CD8 cells following vir
cells following anti-CD3 stimulation, for example, 24.2/21.5 = 1.1. (D) The per
following anti-CD3 stimulation. Mean percentages F SE are shown.levels in whole brain. Mice were injected with MHV-JHM,
MHV-A59, or saline (sham). Total RNA was isolated from
brains harvested on days 3, 5, and 7 postinjection. With the
exception of IL-18 and transforming growth factor (TGF)-h,
which were consistently elevated from background even in
uninoculated brain (data not shown), saline injections did not
induce detectable levels of mRNA message for the cytokines
examined (Fig. 2). Macrophage migration inhibitory factor
(MIF) (data not shown) and tumor neurosis factor (TNF)-a
(Fig. 2) mRNA transcripts were strongly and similarly
enhanced in both MHV-JHM and MHV-A59 infections.ells isolated from infected brains were stimulated with viral peptides or anti-
er five experiments). Cells were stained for the detection of CD8 and IFNg.
t peptide, following both infections, results in negligible amounts of IFNg+
one representative experiment. These negative controls were not run every
are shown and are represented by the IFNg+ CD8 cells in the upper right-
al peptide stimulation was normalized against the percentage of IFNg+ CD8
centage of IFNg+ total cells within the mononuclear gate was determined
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profile distinct from that following MHV-A59 infection.
Most striking was the difference in the induction of IFNh
and IFNgmRNA levels. IFNhmessage was induced early in
MHV-JHM infection, before the infiltration of peripheral
immune cells, and continuously transcribed into day 7, after
the arrival of peripheral immune cells (Fig. 2). This differed
from MHV-A59 infection where moderate IFNh mRNA
accumulation evident at day 3 was further reduced by day
7. In contrast to its ability to induce IFNh, IL-12 p40 and
IFNg messages were not detected until 5 days after MHV-
JHM infection, but were already evident 3 days following
MHV-A59 infection (Fig. 2). These differences in interferon
transcript levels could significantly influence the direct
ability to clear MHV, as well as the infiltration of T cells into
the brain (Yasuda et al., 1999; Zou et al., 1999).
MHV-JHM infection results in a diminished CD8 T cell
presence in the CNS
The ability of MHV-JHM infection to influence T cell
infiltration was evaluated. Following MHV infection, lym-
phocytes begin to enter the brain about day 5 with their
numbers peaking at about day 7 when virus-specific
cytolytic CD8 T cells are apparent (Castro et al., 1994;
Marten et al., 2001). Therefore, mononuclear cells were
isolated from infected brains on day 7 and stained to
distinguish CD8, CD4, and NK1.1 cells. MHV-JHM-
infected brains yielded approximately a 2.5-fold decrease
in the percentage of CD8 T cells within the infiltrating cell
population as compared to MHV-A59-infected brains. The
lack of a difference in the percentage of CD4 T cells and
NK T cells within the brains suggested that they contrib-
uted less than CD8 T cells to the observed differences in
pathology (Fig. 3).Fig. 5. Enhanced CD8 T cell apoptosis is seen following MHV-JHM infection. Ce
Histograms shown were gated on CD8-positive cells. Control panel represents ce
staining. One representative experiment of three is shown. The intensity of Annexin
the assay parameters of the manufacturer.Unlike IFNh, IFNg is critical in MHV clearance (Marten
et al., 2001; Parra et al., 1999; Schijns et al., 1998). Thus,
the capacity of CD8 T cells to produce IFNg was also
examined by intracellular staining. Mononuclear cells iso-
lated from infected brains were stimulated with a control
peptide or viral peptides (S510 or S598). Whether other
epitopes exist on the MHV-A59 background is currently
unknown (Marten et al., 2001). As previously demonstrated
(Castro et al., 1994), the S510 epitope was immunodomi-
nant in MHV-JHM infection (Fig. 4A). CD8 cells from
MHV-JHM-infected brains also exhibited a greater response
against the S598 epitope compared to cells from MHV-A59-
infected brains (Fig. 4B). Anti-CD3 activates antigen-expe-
rienced cells (Yee et al., 1994) and was used to characterize
the ability of total CD8 T cell population, which entered the
brain in response to infection, to produce IFNg. To evaluate
the relationship between the anti-CD3 and viral peptide
stimulations, the percentages of IFNg+ CD8 T cells ob-
served following these stimulations were compared (Fig.
4C). MHV-JHM infection resulted in similar percentages of
IFNg+ CD8 T cells in response to either anti-CD3 (21.5%)
or known viral peptides (24.2%), resulting in a viral/anti-
CD3 ratio of 1:1. In contrast, following MHV-A59 infec-
tion, only about 0.29 of the anti-CD3 response reflected that
of the viral peptide S598.
Furthermore, the reduced number of CD8 T cells in the
brain following MHV-JHM infection decreased the potential
for IFNg production within the CNS. When the percentage
of IFNg+ cells within the intact mononuclear gate was
assessed, there was about a 3-fold lower percentage of
IFNg+ cells from MHV-JHM, as compared to MHV-A59,
infected brain (Fig. 4D).
The diminished CD8 T cell presence in MHV-JHM-
infected brains may reflect a microenvironment that does
not augment CD8 T cell infiltration into the CNS. Alterna-lls isolated from infected brains were stained with anti-CD8 and Annexin V.
ll sample (from MHV-JHM-infected brains) in the absence of Annexin V
V staining of negative population from control to sample is consistent with
Fig. 6. Fatal encephalitis is associated with elevated IL-6 synthesis. (A)
Mice were infected intracranially with MHV-JHM or MHV-A59. On days
3, 5, and 7 p.i., animals were perfused and brains were harvested. Total
RNA was extracted and analyzed by RPA. Representative samples shown
from four experiments. (B) Cells were isolated from infected brains on day
7. Cells were incubated in the presence of UV-irradiated virus and
monensin for 5 h at 37 jC, then stained for intracellular IL-6 as described in
Materials and Methods. Experiment was repeated with similar results.
J.D. Rempel et al. / Virology 318 (2004) 381–392386tively, or in addition, this microenvironment may support
enhanced CD8 T cell apoptosis (Fig. 5). This possibility was
examined by staining cells isolated from MHV-JHM- and
MHV-A59-infected brains with anti-CD8 and Annexin V. In
three independent experiments, CD8 T cells from MHV-
JHM-infected brains exhibited enhanced apoptosis com-Fig. 7. MIP-1a, MIP-1h, and MIP-2 mRNA levels are enhanced in MHV-JHM-inf
Fig. 2. Total RNA was isolated from brains and analyzed by RPA. Representativpared to CD8 T cells from MHV-A59-infected brains
(18.0 F 1.7 vs. 10.7 F 2.1; P < 0.05).
MHV-JHM infection induces elevated IL-1 and IL-6
transcripts
Relative to MHV-A59, MHV-JHM infection yielded
greater IL-1a and IL-1h mRNA accumulation, evident as
early as day 3 and continuing through to day 7 (Fig. 6A).
IL-1 is considered a key IL-6 inducer within the CNS
(Gottschall et al., 1994) consistent with the increasing
strength of IL-6 mRNA levels from day 3 to day 7
following MHV-JHM infection (Fig. 6A). In contrast,
MHV-A59 inoculation resulted in moderate IL-6 mRNA
accumulation. The observed disparity in IL-6 mRNA
expression was confirmed by intracellular staining for IL-
6 (Fig. 6B). Mononuclear cells isolated from MHV-JHM-
infected mice resulted in a 3-fold increase in the percent-
age of IL-6-positive cells as compared to those from
MHV-A59-infected mice. Moreover, supernatants of mixed
glial neuronal cultures infected with MHV-JHM had en-
hanced IL-6 production as compared to MHV-A59
(Rempel et al., 2004). Therefore, MHV-JHM infection
induced aberrant levels of IL-6.
MHV-JHM infection is associated with enhanced
macrophage infiltration
MHV-JHM-infected brains exhibited elevated levels of
MIP-1a, MIP-1h, and MIP-2 mRNA as early as day 3 and
through to day 7 (Fig. 7). This suggested that a greater
recruitment of macrophages into the brain could be initiated
early in MHV-JHM infection. This possibility was evaluated
directly by FACS analysis of cells within the analyzed
within the mononuclear cell gate (as determined by forward
and side scatter) and stained with macrophage markers.
Macrophage populations were determined by staining iso-
lated cells with anti-CD45 and either anti-FcgR or anti-
CD11b enabling differentiation between macrophagesected brains. Mice were infected with MHV-A59 or MHV-JHM as stated for
e samples shown from four experiments.
Fig. 8. MHV-JHM infection results in a greater infiltration of macrophages into the brain. (A) Isotype controls reflect percentages from one representative
experiment (MHV-JHM samples). (B) Cells isolated from MHV-JHM- or MHV-A59-infected brains on day 7 were stained for either CD45 and FcR or CD45
and CD11b. Percentages above quadrants reflect the percentage of cells within the upper right-hand quadrant, that is, either CD45 high/FcR high or CD45 high/
CD11b high. One representative experiment. (C) Means F SE for N experiments is shown.
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mediate/CD11b high) (Carson et al., 1998). MHV-JHM-
infected brains demonstrated approximately 2-fold greater
percentages of macrophages defined as either CD45 high/
FcgR high or CD45 high/CD11b high phenotypes (Fig. 8).
B220 staining was more intense following MHV-A59 in-
fection (data not shown), indicating that disparity in CD45
high/FcgR high staining was not due to greater numbers of
B cells in MHV-JHM-infected brains. Thus, strong macro-
phage responses were clearly not protective, but were
associated with severe viral encephalitis.Discussion
The results presented in this report provide a framework
to interpret the biological basis for the extraordinary neuro-
virulence of MHV-JHM. It is apparent that a key decisive
event in the pathogenesis of MHV-JHM is the early activa-
tion of innate immune responses reflected by elevated and
sustained activation of IFNh and IL-6, together with the
accumulation of MIP-1a, MIP-1h, and MIP-2 mRNA. A
subsequent impact on leukocyte recruitment was evident by
the macrophage-dominated cellular infiltrate deficient in
CD8 T cells. This response, and the fatal consequence ofMHV-JHM infection, stood in marked contrast to MHV-
A59 infection where the enhanced induction of IFNg tran-
scripts supported CD8 T cell activity.
Early innate immunity is critical in the first line defense
against viral infections, as well as in directing the develop-
ment of protective adaptive responses. In this study, glial cell
innate immune responses were evaluated at 3 days after
intracranial inoculation, before peripheral mononuclear cell
infiltration, by ribonuclease protection assay (RPA) analysis
of whole brain samples (Marten et al., 2001). At this time,
MHV-JHM and MHV-A59 induced distinct patterns of
cytokine (Figs. 2 and 6) and chemokine (Fig. 7) transcripts.
The RNA profiles of the two infections in vivo became
increasingly divergent over time, corresponding to the infil-
tration of discrete leukocyte populations, suggesting that the
polarization of leukocyte responses emerged out of virally
induced innate CNS immunity and reinforced them.
Throughout the course of MHV-JHM and MHV-A59
infections, mRNA levels of MIF and TNFa were greatly
enhanced (Fig. 2). Both infections also triggered the accu-
mulation of early IFNh transcripts that were sustained in
MHV-JHM infection, but essentially undetectable in MHV-
A59 infection by day 7, perhaps due to the difference in
viral loads (Fig. 2). IFNh production is an essential com-
ponent in the control of some viral infections (Biron et al.,
J.D. Rempel et al. / Virology 318 (2004) 381–3923881999; Orange and Biron, 1996). However, in MHV infec-
tion, continued IFNh appears to have limited benefit,
considering the strong, but clearly ineffective, IFNh tran-
scription seen in MHV-JHM infection (Fig. 2) and the
inability of exogenous IFNh to protect against MHV
infection of astrocytoma cells (unpublished data). In con-
trast, IFNg is considered essential for MHV clearance as
observed by an increase in mortality among IFNg-knockout
and IFNg receptor-knockout mice infected with attenuated
MHV strains (Marten et al., 2001; Parra et al., 1999; Schijns
et al., 1998). Interferons also impact T cell responses. The
enhanced presence of IFNh might impede T cell activity as
demonstrated in experimental models of MS, where IFNh
treatment ameliorated disease impairing T cell proliferation
and migration into the brain (Yasuda et al., 1999; Zou et al.,
1999). IFNg, on the other hand, promotes the T cell
migration into the brain in part by upregulating adhesion
and co-stimulatory molecules within the CNS and the
periphery (Grau et al., 1997). Therefore, the lag in IFNg
mRNA expression and the enhanced IFNh, compared to
IFNg, transcript levels following MHV-JHM inoculation
(Fig. 2) could be instrumental to the failure to control viral
replication both directly and indirectly resulting in the lack
of appropriate support for CD8 T cells (Figs. 3, 4, and 5).
The early (d. 3) resident brain cell, possibly neuronal,
transcription of IFNg mRNA in MHV-A59 infection defines
an environment that would be more supportive of CD8 T
cell responses (Mori et al., 2001).
Due to the established importance of CD8 T cells and
IFNg in the control of MHV infection, the capacity of CD8
T cells to produce IFNg in response to the known viral
epitopes was evaluated. Anti-CD3 stimulation was used as a
positive control and to quantitate the capacity of the total
CD8 T cell population to produce IFNg. In MHV-JHM
infection, the known viral epitopes reflected the full poten-
tial for antigen-experienced cells to produce IFNg following
anti-CD3 stimulation (indicating that in MHV-JHM infec-
tion, the response from the anti-CD3 stimulation is repre-
sentative of the viral epitope stimulations, Fig. 4C). In
contrast, following MHV-A59 infection, the viral epitope
stimulations were a fraction (0.29) of the anti-CD3 stimu-
lation. This suggests that an undefined immunodominant
epitope, capable of inducing IFNg synthesis, exists within
the MHV-A59 genome that is absent in MHV-JHM. Alter-
natively, this may reflect the activation of non-virus-specific
CD8 cells or some combination of these events (Bergmann
et al., 1999). The diminished CD8 T cell presence in MHV-
JHM-infected brains also appeared to reduce the potential
for IFNg production in the brain, resulting in a 3-fold lower
potential percentage of IFNg+ mononuclear cells isolated
from the MHV-JHM-infected brain as compared to MHV-
A59-infected brain (Fig. 4D).
The differences in the CD8 T cell presence in the brain
following MHV-JHM and MHV-A59 infections were asso-
ciated with increased CD8 cell apoptosis in MHV-JHM
infection (Fig. 5). The enhanced CD8 apoptosis may reflectclonal exhaustion of anti-viral CD8 T cells due to the high
antigenic burden of elevated MHV-JHM titers (Moskophidis
et al., 1993). Alternatively, macrophages recruited into the
brain upon MHV-JHM infection (Fig. 8) may instigate or
amplify CD8 T cell apoptosis, as activated macrophages can
induce premature CD8 T cell apoptosis (Bronte et al., 1998).
Moreover, enhanced T cell apoptosis was observed within a
week of a lethal influenza viral strain HK483 concomitant
with elevated MIP-1a production within the brain (Tumpey
et al., 2000). Further studies should determine whether
macrophage activity influences CD8 T cell survival in
MHV-JHM infection.
Importantly, the failure of MHV-JHM infection to induce
protective T cell responses did not reflect a generalized
immune suppression. On the contrary, robust transcription
of IL-1 and IL-6 mRNA following MHV-JHM, but not
MHV-A59, infection was evident (Fig. 6). The ability of
MHV-JHM to induce greater production of IL-6 protein was
confirmed by intracellular cytokine staining of cells isolated
from the brain (Fig. 6B) and in vitro within the supernatant of
mixed glial neuronal cultures (Rempel et al., 2004). Chronic
IL-6 production has been implicated in CNS inflammatory
diseases including experimental autoimmune encephalomy-
elitis (Merrill, 1992; Okuda et al., 1999; Sun et al., 1995;
Vandenabeele and Fiers, 1991). High levels of IL-6 tran-
scripts, in the presence of either IFNh or IL-1 message, have
also been documented in lethal encephalitic viral infections
(Parra et al., 1997; Theil et al., 2000; Wesselingh et al.,
1994). Astrocytes are a main reservoir for MHV within the
CNS and previously have been shown to be a primary
producer of IL-6 following MHV infection (Sun et al.,
1995). Negligible FACS co-staining of IL-6 with CD8 or
CD11b (data not shown) supported the probability that
astrocytes were the source of the IL-6 observed here. The
contribution of MHV-JHM-induced IL-6 production to CNS
responses is the subject of an ongoing investigation using
mixed glial neuronal cultures.
MHV-JHM infection induced elevated levels of MIP-1a,
MIP-1h, and MIP-2 transcripts by glial cells (day 3 p.i.)
compared to MHV-A59 (Fig. 7). Activated glial cells can
produce chemokines thereby influencing the composition of
the ensuing cellular infiltrate. In vitro and in vivo studies
have demonstrated that glial cells produce MIP-1a and
MIP-1h, along with RANTES, in response to MHV and
other CNS infections (Asensio et al., 1999; Hoffman et al.,
1999; Kitai et al., 2000; Lane et al., 1998). MIP-1a and
MIP-1h predominately enhanced the migration of macro-
phages, eosinophils, and T cells (Baggiolini et al., 1994).
Upregulation of MIP-1 message following MHV-JHM in-
fection corresponded with elevated CD45 high/FcR high or
CD45 high/CD11b high staining positive cells assessed
within a mononuclear cell gate (Carson et al., 1998). These
cells are most likely macrophages as staining with anti-
B220 and anti-NK1.1 was, respectively, diminished and
similar from MHV-JHM compared to MHV-A59-infected
brains (data not shown, Fig. 3). Although macrophages
J.D. Rempel et al. / Virology 318 (2004) 381–392 389often play a protective role in immune defense, their
presence has also been associated with inflammatory dis-
eases, lethal viral infections, and neurodegeneration (Lid-
bury et al., 2000; Smits et al., 2000; Xiong et al., 1999).
Severe MHV infections have been previously associated
with increased macrophage activation, seen in the upregu-
lation of inducible nitric oxide synthase message in the brain
and macrophage procoagulant activity in the periphery
(Fingerote et al., 1996; Parra et al., 1997). It is probable
that the heightened MIP-2 mRNA levels that were observed
in MHV-JHM infection are chemotatic for neutrophils.
Preliminary experiments with anti-Ly-6G monoclonal anti-
body (RB6, using a polynuclear cell gate) revealed a 1.6- to
2-fold greater presence of neutrophils in MHV-JHM-
infected brains as compared to MHV-A59 (data not shown).
Future studies may demonstrate that neutrophils contribute
to the limited protection seen in wild-type MHV-JHM
infection, as observed in broader protection seen following
an attenuated MHV-JHM viral infection (Zhou et al., 2003).
However, taken together, the chemokine and cellular infil-
tration patterns observed here support our conclusion that
MHV-JHM infection induces a pattern of immune responses
that may be detrimental to recovery.
Understanding how a virus, especially one as complex as
MHV, manipulates the host immune response and the
resulting disease is a daunting endeavor and requires con-
sideration of both viral genetics and host responses. An
increasing number of viral components have been found to
activate different immune responses, including IFNg down-
regulation and apoptosis (Basler et al., 2000; Chen et al.,
2001; Park et al., 2001). Considering the genetic similarity
of MHV-JHM and MHV-A59, it is likely that distinct viral
gene products will be found to impact immune responses.
Zhang et al. (1998) reported that expression of MHV-JHM
hemagglutinin/esterase, using defective interfering particles,
in a MHV-A59 infection enhances the accumulation of IL-6
mRNA in vitro. In addition, other studies in our laboratory
(submitted) indicate that elevated MIP-1 transcripts and
macrophage recruitment by MHV-JHM was associated with
enhanced mortality following infection with a chimeric
virus containing the MHV-JHM spike gene expressed on
the MHV-A59 background.
Our study, as well as those by others, provides clues to
understanding how viruses manipulate the immune response
to CNS infection, thereby altering the course of disease. It is
hoped that these investigations will provide insight into
potential therapeutic avenues for treatment of viral enceph-
alitis and demyelination.Materials and Methods
Mice and viruses
Age-matched (5–6 weeks old) male C57Bl/6 mice were
infected intracranially with 30 Al of MHV-JHM (also knownas MHV-4, LD50 3 PFU) at 10 PFU (Phillips et al., 1999)
while under methoxyflurane anesthesia (Pitman-Moore Inc.,
Washington Crossing, NJ), the following control inocula-
tions were given: diluent or MHV-A59 (LD50 4680 PFU).
MHV-A59 results in mild encephalitis at 10 PFU (Phillips et
al., 1999; Talbot and Buchmeier, 1985). Therefore, MHV-
A59 was also administered at 1000 PFU, a dose that
produces similar disease scores as MHV-JHM on day 7,
the peak of encephalitis (Fig. 1). Day 7 was used as an end
point, since mice infected with MHV-JHM generally suc-
cumbed to infection between days 7 and 10. On days 3, 5,
and 7, animals were anesthetized with chloral hydrate
(Sigma, St. Louis, MO) and perfused with saline. The brains
were removed, and halves were used for either plaque
assays or RNA isolation. In other experiments, cells were
harvested from the brains of infected mice to assess extra-
cellular surface markers and intracellular cytokine staining
by FACS analysis.
Clinical disease
Clinical disease provided an external reference for the
degree of encephalitis. Clinical disease was scored on day 7
as disease signs were not consistently evident at day 5.
Briefly, disease scores ranged as follows: 0, no clinical
signs; 1, ruffled hair; 2 ruffled hair, hunched back and slight
impairment in mobility; 3, ruffled hair, hunched back and
extreme impairment of mobility; and 4, mortality.
Mononuclear cell isolation from the brain
Mononuclear cells were isolated from perfused brains as
previously described (Haring et al., 2001). Four to six mice
per group were used in each experiment. Briefly, brains
were removed and placed in Petri dishes containing media
consisting of RPMI (GibcoBRL, Grand Island, NY) and
10% fetal calf serum (FCS, HyClone, Logan, UT). To obtain
single cell suspensions, brains were ground between frosted
slides and triturated with a wide bore pipette. Cell suspen-
sions were transferred to 15-ml conical tubes containing
90% percoll (Amersham Pharmacia, Piscataway, NJ) result-
ing in a final percoll concentration of 30%. The suspensions
were spun at 320  g for 30 min at 4 jC. The lipids and
supernatant were decanted. The remaining cells were pooled
within a group, washed with media, underlayed with Lym-
pholyte M (Cedarlane, Hornby, ON), and centrifuged at
1000  g for 20 min at room temperature. The interface was
collected and washed with media. Total viable cells were
counted by trypan blue exclusion and the number of cells
per brain was estimated. Approximately 450000 cells per
brain were isolated per group (Fig. 1).
Flow cytometry
All staining reagents were acquired from BD Bioscien-
ces Pharmingen, San Diego, CA. Isolated cells were used
J.D. Rempel et al. / Virology 318 (2004) 381–392390at about 250000 cells per tube and analyzed within the
mononuclear cell gate as determined by forward and side
scatter. T cells were detected by Cy-Chrome (CyC)-
conjugated rat anti-mouse CD8a (clone 53-6.7) and R-
phycoerytrin (PE)-anti-CD4 (clone H129.19) staining. NK
cells were identified with PE-anti-NK1.1 (clone PK136).
FITC-conjugated Annexin V was used to detect apoptotic
CD8 T cells according to manufacturer’s instructions. To
identify macrophage populations, cells were stained with
CyC-anti-CD45 (clone 30F11) and fluorescein isothiocya-
nate (FITC)-conjugated rat anti-mouse FcR (clone 2.4G2)
or PE-conjugated CD11b (clone M1/70).
The potential of CD8 T cells to produce IFNg was
evaluated by intracellular cytokine staining (Haring et al.,
2001). Isolated cells were incubated for 5 h at 37 jC in
10% FCS–RPMI containing brefeldin A in the presence
of viral peptides specific for known CD8 epitopes, spike
glycoprotein S510-518 or S598-605 (1 AM), or anti-CD3
(10 Ag/ml). IFNg was detected with FITC-anti-IFNg
(clone XMG1.2). The percentage of mononuclear cells
staining for intracellular IL-6 was determined. Cells were
stimulated with media or UV-irradiated virus in the
presence of monensin for 5 h at 37 jC and stained with
PE-conjugated anti-IL-6 (clone MP5-20F3) as described
(Saio et al., 2001; Schuerwegh et al., 2001). The percent-
age of T cells and macrophages were estimated using a
mononuclear gate. All gates were verified by back-gating
to the forward or side scatter plot. Stained cells were
collected on FASCScan (Becton Dickinson, Franklin
Lakes, NJ) and analyzed with CellQuest software (BD
Biosciences Pharmingen).
Ribonuclease protection assay
Total RNA was extracted from the brains of sham and
MHV inoculated mice on days 3, 5, and 7 post infection
using TRIzol reagent (GibcoBRL). Cytokine and chemo-
kine RNA messages were quantified by RPA (Stalder and
Campbell, 1994). Templates (BD PharMingen) were la-
beled with UTP-P32 (Amersham Pharmacia). Signal in-
tensity was determined from scanned autoradiographs
using the NIH Image 1.61 software. Target bands were
normalized against the ribosomal subunit L32 RNA.Acknowledgments
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